Samsung Biologics Union Launches First-Ever Strike Over Pay Dispute

The labor union at Samsung Biologics has taken the unprecedented step of launching its first-ever full-scale strike, a significant development for the company and the broader Samsung Group. The walkout, set to last from May 1st to May 5th, underscores the deep divisions between the union and management over compensation.

At the heart of the conflict are the union's demands for substantial financial rewards. They are seeking a 30 million won bonus for each employee, a 14% increase in base wages, and a 20% share of operating profits as performance bonuses. These demands reflect a strong assertion of the workers' contributions to the company's success.

However, the company's counter-offer of a mere 6.2% wage increase has proven insufficient, leading to the current impasse. Negotiations, which have been ongoing since December, have failed to bridge the gap, forcing the union to resort to industrial action. This strike marks a critical juncture for Samsung Biologics, highlighting the challenges in balancing corporate profitability with employee compensation expectations.